证券代码：688175 证券简称：高凌信息 公告编号：2025-045 珠海高凌信息科技股份有限公司 第三届董事会第二十九次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任 一、董事会会议召开情况 珠海高凌信息科技股份有限公司（以下简称"公司"）第三届董事会第二十 九次会议于 2025 年 7 月 4 日以现场结合通讯表决的方式召开，会议通知及相关 材料已于 2025 年 6 月 30 日通过电子邮件方式送达全体董事。本次会议由董事长 冯志峰先生主持，应出席会议董事 9 名，实际出席会议董事 9 名，会议的召集、 召开和表决程序符合《中华人民共和国公司法》（以下简称《公司法》）等法律、 法规、规范性文件及《珠海高凌信息科技股份有限公司章程》（以下简称《公司 章程》）的有关规定，形成的决议合法有效。 二、董事会会议审议情况 （一）审议通过《关于取消监事会、变更经营范围并修订<公司章程>的议 案》 为进一步完善公司治理结构，提高公司规范运作和科学决策水平，奠定公司 长期稳定健康发展的坚实基础，根据《公司法》《中华人民 ...

Summary of Key Points Core Viewpoint - The shareholder, Jiaxing Zhanzheng, has completed a share reduction plan, selling a total of 528,859 shares, which represents 0.41% of the company's total share capital, due to funding needs [1][2]. Group 1: Shareholder Information - Before the reduction plan, Jiaxing Zhanzheng held 528,859 shares, accounting for 0.41% of the total share capital [1]. - The shares were acquired prior to the company's initial public offering (IPO) and have been released from restrictions [1]. Group 2: Reduction Plan Implementation - The reduction plan was disclosed on June 25, 2025, and the shares were sold through centralized bidding [2]. - The total number of shares reduced was 528,859, completed between June 30, 2025, and July 1, 2025 [2][4]. - The share price during the reduction ranged from 20.21 to 20.77 yuan per share, resulting in a total amount of 10,811,267.77 yuan [2]. Group 3: Current Shareholding Status - Following the completion of the reduction, Jiaxing Zhanzheng currently holds 0 shares, representing 0% of the total share capital [3][4]. - The actual reduction was consistent with the previously disclosed plan, and the plan was fully executed without any early termination [4].

Group 1 - Guizhou Moutai has repurchased a total of 3.3821 million shares as of June 30, 2025, accounting for 0.2692% of the total share capital, with a total expenditure of 5.202 billion yuan [2] - Luxshare Precision is planning to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global financing capabilities and governance transparency [2] - Huazhong Xinchuang has received a project notification from a leading domestic eVTOL manufacturer for the development and supply of an intelligent cockpit multimedia display system [3] Group 2 - Meinohua expects a net profit of 46 million to 52 million yuan for the first half of 2025, representing a year-on-year increase of 142.84% to 174.52% [4] - Jiangnan Water has received a report from shareholder Lianan Life Insurance indicating an increase in shareholding by 46.99 million shares, representing 5.03% of the total share capital [5] - Huasen Pharmaceutical has received approval for clinical trials of its CX001 sustained-release tablets, marking a milestone for its innovative drug development platform [6] Group 3 - Zongshen Power anticipates a net profit growth of 70% to 100% for the first half of the year [7] - Yutong Bus reported a sales volume of 5,919 units in June, a year-on-year increase of 24.79% [7] - Guangzhou Port expects a 7.0% year-on-year increase in container throughput for June 2025 [7] Group 4 - Data Port's shareholders plan to reduce their holdings by up to 1.74% and 0.26% of the company's shares [9] - Humanwell Healthcare's shareholder plans to increase its stake by 1% to 2% [9] - Nengte Technology plans to repurchase shares worth between 300 million to 500 million yuan [10]

Group 1 - CITIC Construction Investment has received approval from the China Securities Regulatory Commission to issue perpetual subordinated bonds with a total face value of no more than 20 billion yuan [1] - Bluefocus Technology has received a loan commitment of up to 900 million yuan from CITIC Bank for stock repurchase [1] - Huaren Pharmaceutical's subsidiary has received approval for the listing of Bumetanide raw materials, which are used to treat severe heart failure and hypertension emergencies [3] Group 2 - Betta Pharmaceuticals has received approval for the listing of Enasidenib capsules in Macau, aimed at treating ALK-positive locally advanced or metastatic non-small cell lung cancer [4] - Juewei Food plans to use 110 million yuan of idle fundraising for cash management, with an expected annual yield of 1.00%-1.89% [6] - China Huadian has successfully completed the issuance of 1 billion yuan medium-term notes with a coupon rate of 1.95% [9] Group 3 - Fosun Pharma's subsidiary has received a GMP certificate from the Belgian Federal Agency for Medicines and Health Products for the production facilities of two monoclonal antibodies [11] - China Nuclear Engineering has signed a civil engineering contract for the Taishan Nuclear Power Units 3 and 4 [13] - Kanglongda has faced administrative regulatory measures from the Zhejiang Securities Regulatory Bureau due to the failure of performance commitment parties to fulfill compensation obligations [15] Group 4 - Gaoling Information has received three invention patent certificates in the second quarter, covering various technological fields [16] - Weimais plans to use 190 million yuan of excess fundraising to increase capital in its subsidiary for building a new energy vehicle powertrain production base [17] - Huazhong Technology has received a project designation notice from a leading eVTOL manufacturer for the development and supply of an intelligent cockpit multimedia display system [19] Group 5 - Madi Technology expects a net profit of 25 million to 27 million yuan for the first half of 2025, marking a turnaround from a loss in the previous year [19] - Dazhong Mining's subsidiary has obtained a mining license for the Zhouyoufang Iron Mine, increasing production capacity to 6.5 million tons per year [20] - Zhongguancun's subsidiary has had its application for the listing of Arolol hydrochloride tablets accepted by the National Medical Products Administration [21] Group 6 - Tianhong Co. has signed a property management contract worth 15 million yuan with a local company [22] - Dong'an Power has secured nine new market designation agreements in the second quarter, with a projected total sales volume of 1.5 million units [24] - Zhujiang Co. has appointed Zhao Kun as the new deputy general manager [25] Group 7 - Jinyi Industrial has won a bid for a project worth 335 million yuan from the China Railway Shanghai Bureau Group [26] - Kangchen Pharmaceutical has received a clinical trial notification for its innovative drug KC1086, aimed at treating advanced solid tumors [27] - Changhua Group has received a project designation notice from a new energy vehicle company, with an expected total sales amount of 970 million yuan [29] Group 8 - Lingxiao Pump Industry plans to use 60 million yuan of idle funds to purchase financial products [31] - Mould Technology has received a project designation for exterior parts from a well-known North American electric vehicle company, with an expected total sales of 1.236 billion yuan [34] - Fulongma has pre-bid for five sanitation service projects in June, with a total contract amount of 181 million yuan [35] Group 9 - Changchun High-tech plans to issue H-shares and list on the Hong Kong Stock Exchange [36] - *ST Yuancheng is under investigation by the CSRC for suspected false financial disclosures [37] - Beilu Pharmaceutical's subsidiary has received approval for the listing of Iopamidol raw materials [38] Group 10 - Zhejiang Liming's shareholder plans to reduce their stake by up to 2.93% [39] - Zhejiang Liming's actual controller has committed not to reduce their holdings within a year [40] - SAIC Motor reported a total vehicle sales of 2.0526 million units in the first half of 2025, a year-on-year increase of 12.35% [41] Group 11 - Xinhongcheng expects a net profit increase of 50%-70% for the first half of 2025 [42] - Xianhe Co. plans to invest 11 billion yuan in a bamboo pulp paper integrated project [42] - Great Wall Motors reported a total vehicle sales of 569,800 units in the first half of 2025, a year-on-year increase of 1.81% [43] Group 12 - Dongfeng Co. received a government subsidy of 10 million yuan [44] - Zhongke Environmental Protection has acquired two water environmental companies in Guangxi for a total of 353 million yuan [45] - Anji Food's H-share public offering is priced at 60 Hong Kong dollars per share [46]

证券代码：688175 证券简称：高凌信息 公告编号：2025-044 珠海高凌信息科技股份有限公司 特定股东股份减持计划实施结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 股东持股的基本情况 本次减持计划实施前，珠海高凌信息科技股份有限公司（以下简称"公司"） 股东嘉兴战新高领股权投资合伙企业（有限合伙）（以下简称"嘉兴战新"）持有 公司股份 528,859 股，占公司总股本的 0.41%。 上述股份为公司首次公开发行前取得的股份，以及由该等股份因资本公积转 增股本取得的股份，首次公开发行前取得的股份已解除限售并上市流通。 减持计划的实施结果情况 2025 年 6 月 25 日，公司披露了《特定股东减持股份计划公告》（公告编号： 2025-040）。减持计划主要内容如下： 因股东资金需求，公司股东嘉兴战新拟通过集中竞价、大宗交易或两种方式 相结合的方式减持所持公司股份，减持股份数量不超过 528,859 股，占公司总股 本比例不超过 0.41%，上述减持自减持计划公告披露之日起 3 ...

二、取得发明专利对公司的影响 上述发明专利的取得是公司重要核心技术的体现和延伸，本次专利的获得不会 对公司近期经营产生重大影响，但有利于进一步完善公司知识产权保护体系，发挥 自主知识产权的技术优势，促进技术创新，保持技术领先，提升公司核心竞争力。 关于公司获得发明专利证书的自愿性披露公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 珠海高凌信息科技股份有限公司（以下简称"公司"）于 2025 年第二季度收到 3 项国家知识产权局颁发的发明专利证书，具体如下： | 序号 | 发明专利 名称 | | 专利号 | 专利申请日 | 授权公告日 | 专利权人 | 专利 期限 | | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 拟态环境下操作 系统命令行配置 方法及系统 | ZL | 202111617814.6 | 2021-12-28 | 2025-05-23 | 河 南 信 大 网 御 科 技 有限公司， 珠 海 高 凌 信 息 科 技 股 份 有 限 公司 | ...

Core Viewpoint - The company has decided to postpone the timeline for certain fundraising projects to ensure better alignment with its development requirements, while maintaining the original investment purposes and scales [4][5][9]. Fundraising Overview - The company raised a total of RMB 1,200,350,429.60 through the issuance of 23,226,595 shares at a price of RMB 51.68 per share, with a net amount of RMB 1,110,273,504.59 after deducting issuance costs [1]. - As of May 31, 2025, the total balance of the fundraising in special accounts is RMB 173,373,500, which does not include RMB 749,000,000 used for cash management in financial products [2][3]. Fundraising Project Status - The total investment amount for the fundraising projects is RMB 106,107,350, with cumulative investments of RMB 25,713,170 as of May 31, 2025 [4]. Reasons for Project Postponement - The postponement is due to delays in project implementation, particularly in the "Internal Security Communication System Upgrade Project" and "Communication Network Information Security and Big Data Operation Product Upgrade Project," caused by external environmental factors and changes in client needs [5][6][8]. Measures to Ensure Completion - The company will adhere to relevant regulations and strengthen the management and supervision of fundraising usage to ensure compliance and effective project implementation [9]. Necessity and Feasibility of Projects - The company has reassessed the necessity and feasibility of the postponed projects, concluding that they remain essential and viable despite the delays [10][11][12][13][14]. Impact of Postponement - The postponement will not materially affect the implementation of the projects or the company's normal operations, and it aligns with the long-term development strategy [15]. Review Procedures - The postponement has been approved by the company's board and supervisory committee, confirming compliance with legal and regulatory requirements [15][16].

长城证券股份有限公司 关于珠海高凌信息科技股份有限公司部分募投项目延期的核查 意见 公司对募集资金采取了专户存储管理，设立了相关募集资金专项账户。募集 资金到账后，已全部存放于募集资金专项账户内，并与保荐机构、存放募集资金 的银行签署了募集资金三方监管协议。 截至 2025 年 5 月 31 日，公司首次公开发行股票募集资金在专用账户的存储 情况如下： 单位：万元 | 开户银行 | 银行账号 | 账户余额 | | --- | --- | --- | | 平安银行横琴粤澳深度合作区分行营业部 | 15819299210050 | 2,383.77 | | 交通银行股份有限公司珠海体育中心支行 | 444000916013000691321 | 1,518.83 | | 平安银行横琴粤澳深度合作区分行营业部 | 15551087090047 | 3,423.34 | | 平安银行横琴粤澳深度合作区分行营业部 | 15634528920069 | 3,911.45 | | 交通银行股份有限公司珠海体育中心支行 | 444000916013000691245 | 999.90 | | 平安银行横琴粤澳深度合作区分行营 ...

证券代码：688175 证券简称：高凌信息 公告编号：2025-042 珠海高凌信息科技股份有限公司 关于部分募投项目延期的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 珠海高凌信息科技股份有限公司（以下简称"公司"）于 2025 年 6 月 29 日召开了公司第三届董事会第二十八次会议、第三届监事会第二十五次会议，审 议通过了《关于公司部分募投项目延期的议案》，同意公司对部分首次公开发行 股票募集资金投资项目（以下简称"募投项目"）达到预定可使用状态的时间进 行延期。本次延期未改变募投项目的投资内容、投资总额、实施主体，不会对募 投项目的实施造成实质性影响。公司董事会、监事会对上述事项发表了明确的同 意意见，保荐机构长城证券股份有限公司（以下简称"保荐机构"）对上述事项 发表了明确的核查意见，本事项无需提交股东大会审议。现将具体情况公告如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意珠海高凌信息科技股份有限公司首次 公开发行股票注册的批复》（证监许可[2022]201 号）文件核准，由主承销商长 ...

证券代码：688175 证券简称：高凌信息 公告编号：2025-041 珠海高凌信息科技股份有限公司 第三届监事会第二十五次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 珠海高凌信息科技股份有限公司（以下简称"公司"）第三届监事会第二十 五次会议于 2025 年 6 月 29 日以通讯表决的方式召开，会议通知及相关材料已于 2025 年 6 月 26 日以电子邮件的方式发出。本次会议应出席会议监事 3 名，实际 出席会议监事 3 名。本次会议的召集、召开和表决程序符合《中华人民共和国公 司法》等法律、法规、规范性文件及《珠海高凌信息科技股份有限公司章程》的 相关规定，形成的决议合法有效。 二、监事会会议审议情况 （一）审议通过《关于公司部分募投项目延期的议案》 经审核，监事会认为本次募投项目延期是公司根据募投项目的实际情况作出 的审慎决定，不会对项目实施和公司的正常经营产生重大不利影响，不存在变相 改变募集资金投向和损害股东特别是中小股东利益的情形。决策和审批程序符合 相关法律法规的 ...